Denteric’s GPV381 enters Phase 2, but can a therapeutic vaccine really change periodontitis care?
Denteric’s GPV381 has entered Phase 2 in periodontitis. Read why the gingipain-targeting vaccine could test a new treatment model.
Pharma & Biotech
Medical Devices & Diagnostics
ImpetusDX launches rapid oral microbial test to bring real-time diagnostics to dental care
ImpetusDX has introduced its IDX Oral Health Microbial Testing panel, a rapid saliva-based diagnostic tool that identifies key oral bacteria within 24 to 48 hours, offering a streamlined way to detect periodontal pathogens during routine hygiene visits. Developed by the oral diagnostics company and processed through the CAP-accredited and CLIA-certified lab infrastructure of Physicians Choice